(Bloomberg) -- The Democratic Republic of Congo on Monday began the first trial to test the effectiveness and safety of four experimental drugs in the treatment of Ebola, according to the World Health Organization.
“While our focus remains on bringing this outbreak to an end, the launch of the randomized control trial in DRC is an important step towards finally finding an Ebola treatment,” WHO Director-General Tedros Adhanom Ghebreyesus said in a statement on the organization's website.
At least 191 people have died since August in an outbreak of the virus centered in the town of Beni, the worst occurrence of the illness since more than 11,000 people died in West Africa between 2014 and 2016.
To contact the reporter on this story: Ignatius Ssuuna in Goma at issuuna@bloomberg.net
To contact the editors responsible for this story: Hilton Shone at hshone@bloomberg.net, Pauline Bax
©2018 Bloomberg L.P.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
